Organoidsciences Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	2,521	1,953	1,591	438.24
Revenue Growth (YoY)	58.43%	22.77%	263.05%	-
Cost of Revenue	46.21	42.8	44.5	26.26
Gross Profit	2,475	1,910	1,547	411.98
Selling, General & Admin	10,402	8,563	6,211	4,560
Research & Development	5,619	5,217	4,776	6,227
Other Operating Expenses	21.29	32.11	44.04	38.26
Operating Expenses	16,411	14,145	11,341	10,965
Operating Income	-13,936	-12,235	-9,795	-10,553
Interest Expense	-349.71	-3,190	-5,992	-4,906
Interest & Investment Income	254.77	481.1	924.75	582.06
Currency Exchange Gain (Loss)	14.08	19.26	18.98	-
Other Non Operating Income (Expenses)	148.64	3,226	-24,068	-9,235
EBT Excluding Unusual Items	-13,868	-11,699	-38,911	-24,111
Gain (Loss) on Sale of Investments	284.29	163.05	43.05	-
Pretax Income	-13,584	-11,536	-38,868	-24,111
Earnings From Continuing Operations	-13,584	-11,536	-38,868	-24,111
Minority Interest in Earnings	303.99	289.06	180.86	-
Net Income	-13,280	-11,246	-38,687	-24,111
Net Income to Common	-13,280	-11,246	-38,687	-24,111
Shares Outstanding (Basic)	5	4	3	3
Shares Outstanding (Diluted)	5	4	3	3
Shares Change (YoY)	90.34%	45.84%	-	-
EPS (Basic)	-2434.51	-2690.83	-13499.65	-8413.46
EPS (Diluted)	-2434.51	-2690.83	-13499.65	-8413.46
Free Cash Flow	-13,257	-9,808	-8,196	-10,304
Free Cash Flow Per Share	-2430.37	-2346.59	-2859.93	-3595.68
Gross Margin	98.17%	97.81%	97.20%	94.01%
Operating Margin	-552.85%	-626.38%	-615.62%	-2407.94%
Profit Margin	-526.83%	-575.78%	-2431.56%	-5501.84%
Free Cash Flow Margin	-525.93%	-502.11%	-515.13%	-2351.33%
EBITDA	-12,570	-10,931	-8,651	-9,748
D&A For EBITDA	1,366	1,304	1,144	804.46
EBIT	-13,936	-12,235	-9,795	-10,553
Advertising Expenses	-	332.07	139.83	145.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.